Drug: GEMCITABINE Injury: Disease progression Quarter: 2016Q3
Total Records: 49 Number of Pages: 3
Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
---|---|---|---|---|---|---|---|---|
125425471 | GEMCITABINE | Disease progression | CIPLA | 0.00 | 0 | 20160709 | JP | |
125476741 | GEMCITABINE | Disease progression | CIPLA | 0.00 | 0 | 20160712 | AT | |
125524181 | GEMCITABINE | Disease progression | CIPLA | 0.00 | 0 | 20160713 | JP | |
125524461 | GEMCITABINE | Disease progression | CIPLA | 0.00 | 0 | 20160713 | JP | |
125524481 | GEMCITABINE | Disease progression | CIPLA | 0.00 | 0 | 20160713 | JP | |
125528081 | GEMCITABINE | Disease progression | CIPLA | 0.00 | 0 | 20160713 | JP | |
125615341 | GEMCITABINE | Disease progression | CIPLA | 53.00 YR | M | 82 KG | 20160715 | JP |
125819701 | GEMCITABINE | Disease progression | CIPLA | 0.00 | 0 | 20160722 | IN | |
125823541 | GEMCITABINE | Disease progression | CIPLA | 0.00 | 0 | 20160722 | COUNTRY NOT SPECIFIED | |
125823721 | GEMCITABINE | Disease progression | CIPLA | 0.00 | 0 | 20160722 | COUNTRY NOT SPECIFIED | |
125829781 | GEMCITABINE | Disease progression | CIPLA | 0.00 | 0 | 20160722 | ES | |
125973643 | GEMCITABINE | Disease progression | NOVARTIS | 64.00 YR | M | 95 KG | 20160901 | FR |
126666751 | GEMCITABINE | Disease progression | CIPLA | 0.00 | 0 | 20160819 | FR | |
126672261 | GEMCITABINE | Disease progression | CIPLA | 0.00 | 0 | 20160819 | US | |
126705961 | GEMCITABINE | Disease progression | CIPLA | 0.00 | 0 | 20160822 | JP | |
126706141 | GEMCITABINE | Disease progression | CIPLA | 0.00 | 0 | 20160822 | JP | |
126706151 | GEMCITABINE | Disease progression | CIPLA | 0.00 | 0 | 20160822 | JP | |
126735261 | GEMCITABINE | Disease progression | SANDOZ | 41.00 YR | F | 0 | 20160822 | COUNTRY NOT SPECIFIED |
126746921 | GEMCITABINE | Disease progression | CIPLA | 0.00 | 0 | 20160823 | CN | |
126748771 | GEMCITABINE | Disease progression | CIPLA | 0.00 | 0 | 20160823 | CN |
Total Records: 49 Number of Pages: 3